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INTRODUCTION
The mortality from gastric carcinoma has recently decreased
(Akoh and Macintyre, 1992). One of the reasons for the improved
outcome is increased detection of early gastric cancers due to
vigorous endoscopic screening (Kennedy, 1993). However, more
than half of the gastric carcinomas detected are advanced
(Bonenkamp et al, 1993). In the treatment of advanced carcinoma
of the stomach, aggressive lymph node dissection in conjunction
with gastrectomy has been reported to result in a substantial
improvement in survival (Maruyama et al, 1987; Shiu et al, 
1987). Splenectomy or distal pancreaticosplenectomy are often
performed simultaneously with total gastrectomy to facilitate
dissection of the lymph nodes around the splenic hilus and splenic
artery. There have been reports of improved survival with added
splenectomy or distal pancreaticosplenectomy compared with total
gastrectomy alone in patients with gastric cancer (Noguchi et al,
1989; Takagi et al, 1980). However, the possibility of a negative
impact of splenectomy or distal pancreatectomy has been raised
(Sugimachiet et al, 1980; Yoshino et al, 1979; Suehiro et al, 1984;
Maruyama, 1979; Otsuji et al, 1996). Because the spleen makes up
25% of the total lymphoid mass and is an important component of
the reticuloendothelial system, there is an increased long-term risk
of infection following splenectomy (Ellison et al, 1983). Although
some Japanese surgeons have demonstrated that splenic hilar
nodes can be completely dissected without splenectomy (Uyama
et al, 1996), this procedure is not widely used. Several investiga-
tors have demonstrated that patients undergoing pancreatico-
splenectomy in conjunction with total gastrectomy are at risk for
leaks from the stump of the pancreas (Cuschieri et al, 1996). This
predisposes to subphrenic abscess formation, dehiscence of the
visceral anastomoses, and erosion of the blood vessels in the area
of the pancreas, resulting in high peri-operative mortality rates.
Thus, there is no consensus of opinion regarding the therapeutic
value of splenectomy or distal pancreaticosplenectomy.
Clinically, it is thus difficult to decide whether simultaneous
splenectomy or distal pancreaticosplenectomy should be
performed with total gastrectomy in patients with advanced gastric
carcinoma without distant metastasis. What is known, however, is
that these patients have a high risk of lymph node metastasis
around the splenic artery and splenic hilus.
To evaluate the effects of distal pancreaticosplenectomy and
splenectomy on survival, a retrospective analysis of 128 patients
who underwent total gastrectomy for gastric carcinoma was
performed. The post-operative morbidity was compared between
the patients who underwent distal pancreaticosplenectomy or
splenectomy, and those who underwent gastrectomy alone.
PATIENTS AND METHODS
Patients
Between 1983 and 1994, 128 patients underwent total gastrectomy
for gastric carcinoma at the First Department of Surgery, Kyoto
Prefectural University of Medicine, Kyoto, Japan. Of these
patients, 46 (35.9%) underwent pancreaticosplenectomy and total
Total gastrectomy with simultaneous
pancreaticosplenectomy or splenectomy in patients
with advanced gastric carcinoma
E Otsuji, T Yamaguchi, K Sawai, K Okamoto and T Takahashi
First Department of Surgery, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji Kamigyo-ku, Kyoto 602-0841, Japan
Summary A splenectomy or distal pancreaticosplenectomy is often performed simultaneously with total gastrectomy in the treatment of
gastric carcinoma to facilitate dissection of the lymph nodes around the splenic artery and splenic hilus. However, the negative impact of
splenectomy and pancreaticosplenectomy has also been reported. A retrospective analysis was performed to evaluate the outcomes of distal
pancreaticosplenectomy and total gastrectomy, splenectomy and total gastrectomy, and gastrectomy alone in the patients with advanced
gastric carcinoma without distant metastasis. Prognostic factors were examined. No significant differences existed in 5-year survival in the
patients who underwent gastrectomy with splenectomy, gastrectomy with distal pancreaticosplenectomy, or gastrectomy alone. Neither
splenectomy, nor distal pancreaticosplenectomy were prognostic factors. However, distal pancreaticosplenectomy was an independent
predictor of pancreatic fistula. In conclusion, the addition of distal pancreaticosplenectomy or splenectomy to total gastrectomy for gastric
cancer increases the risk of severe complications, but does not improve survival.
Keywords: gastric carcinoma; total gastrectomy; distal pancreatectomy
1789
British Journal of Cancer (1999) 79(11/12), 1789–1793
© 1999 Cancer Research Campaign
Article no. bjoc.1998.0285
Received 28 May 1998
Revised 1 September 1998
Accepted 7 October 1998
Correspondence to: E Otsujigastrectomy, 57 (44.6%) underwent splenectomy and total gastrec-
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Surgical technique
The surgical procedures were performed by several attending
surgeons on the faculty, or by the surgical fellows. Patients with
gastric carcinoma located in the middle or proximal stomach
underwent total gastrectomy by essentially the same technique.
The definitions for classification were taken from the International
Union Against Cancer (UICC) (Hermanek et al, 1987).
Clinicopathologic findings
Information collected from the medical records included the age
and sex of the patient, as well as the size and location of the
primary tumour, the depth of invasion, and whether regional
lymph node metastases were present. The UICC stage, presence
or absence of residual tumour, the operative time, pre-operative
co-morbid conditions, and blood transfusion requirements were
also recorded.
Post-operative complications were reviewed. A complication
was not considered infectious unless confirmed by bacteriologic
cultures.
Statistical methods
Statistical analysis was performed using the NAP system (Version
4.0) programmed by Aoki (1989). The first objective of the
statistical analysis was to examine the influence of each clinical,
pathologic and treatment variable on survival following total
gastrectomy. Information obtained from the univariate analysis
(log-rank test) was applied to survival analysis with covariates
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Table 1 Clinicopathologic findings in the patients who underwent splenectomy and total gastrectomy with or without distal pancreatectomy
Only With With
Variables total gastrectomy splenectomy pancreaticosplenectomy P value
(n = 25) (n = 57) (n = 46)
Age (year, mean) 66.2 58.8 56.8 NS
Sex (male/female) 18/7 31/26 32/14 NS
Tumour size (mm, mean) 54.9 65.9 62.6 NS
Primary tumour (pT2/pT3/pT4) 13/9/3 32/22/3 23/19/4 NS
Location (upper/middle/lower/whole) 13/8/1/3 30/17/2/8 24/18/1/3 NS
Circumference (greater/lesser/anterior/posterior/combined) 9/4/2/4/6 24/8/9/8/8 21/5/8/6/6 NS
Regional lymph nodes (positive/negative) 17/8 35/22 32/14 NS
UICC staging (Ia/Ib/II/IIIa/IIIb/IV) 4/5/15/1 9/15/30/3 1/11/33/1 NS
Residual tumour (R0/R1/R2) 22/1/2 52/0/5 45/1/0 NS
Operative time (min, mean) 246 289 313 < 0.05*
Pre-operative co-morbidity (positive/negative) 15/10 32/25 29/17 NS
Post-operative co-morbidity (positive/negative) 9/16 23/34 21/25 NS
Blood transfusion (positive/negative) 14/11 33/24 27/19 NS
NS, not significant; *significant difference; greater, greater curvature; lesser, lesser curvature; anterior, anterior wall; posterior, posterior wall.
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Figure 1. The 5-year survival rates for the patients who underwent total
gastrectomy with or without splenectomy or pancreaticosplenectomy for
gastric cancer. No significant differences existed between the survival rates
in the three groups. ￿ ￿￿ ￿- -, pancreaticosplenectomy with total gastrectomy; 
— —, splenectomy with total gastrectomy; - - -, total gastrectomy alone
Table 2 Univariate analysis of prognostic variables for survival
Variables P-value
Age (over or under 65 years old) 0.21328
Sex (female/male) 0.18272
Tumour size (over or under 5 cm) 0.00180*
Primary tumour (pT1/pT2/pT3/pT4) 0.00001*
Location (upper/middle/lower/whole) 0.02212*
Regional lymph nodes (N0/N1/N2) 0.00402*
Residual tumour (R0/R1/R2) 0.00213*
Gross appearance (I/II/III/IV/other) 0.01358*
Operative time (over or under 300 min) 0.43562
Pre-operative co-morbidity (positive/negative) 0.87809
Blood transfusion (positive/negative) 0.18302
*Significant difference.using the Cox model of proportional hazards (Cox, 1972). To
analyse the influence of splenectomy or distal pancreatectomy on
survival following gastrectomy, the Kaplan–Meier method and
generalized Wilcoxon test were performed.
The second objective of the statistical analysis was to assess
the incidence of the complications. The incidence of the post-
operative co-morbidities was compared between groups using
11 variables.
RESULTS
Clinicopathologic findings
Significant differences were noted in the operative time between
the groups (Table 1).
Survival rates
The cumulative 5-year survivals of the patients who underwent
total gastrectomy with distal pancreaticosplenectomy, total
gastrectomy with splenectomy and total gastrectomy alone were
40.7%, 55.9% and 54.2% respectively. Using the generalized
Wilcoxon test, a significant difference was not observed between
the groups (Figure 1).
Prognostic factors
Of the 13 clinical and pathologic variables identified by univariate
analysis, six were found to be independent predictors of survival,
and were selected for final proportional-hazards regression. Those
variables were tumour size, depth of cancer invasion, location of
the primary tumour, regional lymph node metastases, residual
tumour, and the gross appearance of the tumour (Table 2).
Multivariate analysis showed that significant prognostic factors
were residual tumour, depth of cancer invasion and the gross
appearance of the tumour. Neither distal pancreaticosplenectomy
nor splenectomy were independent prognostic factors (Table 3).
Complication following total gastrectomy
Pancreatic fistulae were significantly more common following
total gastrectomy with distal pancreaticosplenectomy than
after gastrectomy with splenectomy or total gastrectomy alone
(Table 4).
DISCUSSION
The extent of lymph node dissection with gastrectomy for gastric
carcinoma has been a topic of much discussion (Gall et al, 1985;
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Table 3Multivariate analysis of prognostic variables for survival
Variables Regression coefficient P-value
Depth of cancer invasion 0.44759 0.00082*
Gross appearance 0.42839 0.00279*
Residual tumour 0.35851 0.00479*
Tumour size 0.25439 0.15434
Lymph node metastasis 0.21016 0.15982
Splenectomy or pancreaticosplenectomy 0.08266 0.54194
Location 0.00421 0.97279
*Significant difference.
Table 4Post-operative complications following total gastrectomy
Only With
Complication total gastrectomy splenectomy With pancreaticosplenectomy P-value
Cardiac 0 (0%) 0 (0%) 2 (4.3) NS
Pulmonary 1 (4.0%) 2 (3.5%) 0 (0) NS
Liver dysfunction 2 (8.0%) 3 (5.3%) 4 (8.7) NS
Renal dysfunction 0 (0%) 1 (1.8%) 0 (0) NS
Bleeding 1 (4%) 0 (0%) 1 (2.2) NS
Anastomotic leakage 3 (12.0%) 8 (14.1%) 7 (15.2) NS
Intestinal obstruction 1 (4.0%) 2 (3.5%) 0 (0) NS
Pancreatitis 0 (0%) 1 (1.8%) 1 (2.2) NS
Pancreatic fistula 1 (4.0%) 1 (1.8%) 7 (15.2) 0.0271025*
Wound infection 2 (8.0%) 2 (3.5%) 1 (2.2) NS
NS, not significant; *significant difference.Soga et al, 1979, 1988). Lymphatic flow around the upper portion
of the greater curvature of the stomach has been reported, toward
the nodes around the splenic hilus and splenic artery (Takahashi et
al, 1991). Yoshino et al have reported that spread of carcinoma is
often to the lymph nodes around the splenic hilus and splenic
artery when the primary tumour is located along the greater curva-
ture of the upper third of the stomach (Yoshino et al, 1979).
Simultaneous splenectomy and distal pancreaticosplenectomy
have been advocated as standard procedures for proximal gastric
cancer to facilitate removal of the lymph nodes around the splenic
hilus and artery. The incidence of positive hilar node metastasis in
patients with gastric carcinomas located in the upper third of the
stomach has been reported to be greater than 25% (Fass and
Schumpelick, 1989). In cases of curative total gastrectomy with
splenectomy, the rate of cancerous involvement of the splenic hilar
nodes was found to be about 10% (Sugimachi et al, 1980). In our
study, the incidence of hilar nodal metastasis in patients who
underwent splenectomy simultaneously with total gastrectomy for
gastric carcinoma was 14% (14/103) (unpublished data).
Although splenectomy has been advocated for clearance of the
splenic hilar lymph nodes, the importance of the spleen as a part of
the immune system has only recently been stressed. The spleen is
an important component of the reticuloendothelial system (Ellison
and Fabri, 1983), and serves as a site of T- and B-lymphocyte
interaction, which is important for the secondary immune response
to foreign antigen challenges (Llende et al, 1986). Moreover,
Griffith et al have reported that most of their patients with splenic
hilar nodal metastasis had a primary tumour that had penetrated
through the serosa, and had perigastric lymph node metastasis
(Griffith et al, 1995). The prognosis in these patients was poor
even after radical gastrectomy. Thus, whether or not to preserve
the spleen has been vigorously debated.
In our previous study, the incidence of microscopic lymph node
metastasis around the splenic artery in patients who underwent
distal pancreatectomy simultaneously with total gastrectomy for
gastric carcinoma was 15% (7/46) (unpublished data). Kanai
(1967) has demonstrated, by examining sequential sections of the
distal pancreas and surrounding tissues, that remnant nodes exist
along the splenic artery in 74.7% of patients. This suggests that
organ resection in the absence of true invasion is necessary to
ensure the completeness of nodal dissection. However, Sugimachi
et al (1982) have reported that many patients with nodal metas-
tases at the splenic hilus or around the splenic artery are incurable
with surgery because of factors other than the existence of these
nodal metastases. Moreover, the morbidity after distal pancreatico-
splenectomy and gastrectomy has been reported to be greater than
that after splenectomy and gastrectomy, and gastrectomy alone
(Fortner et al, 1994).
In the present study, we analysed patients with advanced gastric
carcinoma without distant metastasis. It is often difficult to deter-
mine whether combined resection of the spleen or distal pancreas
should be performed as a part of extended radical lymph node
dissection. In this study, the 5-year survival rates of the patients
who underwent distal pancreaticosplenectomy with total gastrec-
tomy, splenectomy with total gastrectomy, or total gastrectomy
alone were not statistically different. Moreover, neither pan-
creaticosplenectomy nor splenectomy were significant prognostic
factors in the patients undergoing total gastrectomy.
The morbidity in patients who have undergone distal pancreati-
cosplenectomy with total gastrectomy has been reported to be
greater than that after splenectomy and gastrectomy, or gastrec-
tomy alone (Fortner et al, 1994; Otsuji et al, 1997). In this study,
the incidence of pancreatic fistulae after distal pancreaticosplenec-
tomy and total gastrectomy was significantly higher than that after
splenectomy and total gastrectomy and total gastrectomy alone.
Because only the in-hospital morbidity was analysed in this
study, the long-term risk of infection following splenectomy was
not considered. Therefore, in patients with gastric cancer, the addi-
tion of distal pancreaticosplenectomy or splenectomy to total
gastrectomy increases the risk of severe complication, but does not
improve survival.
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